Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV)
Stock · NYSE · Health Care
$10.01as of 10/16/2026
Price chart
Active signals
TRLV Signal Track Record
How signals performed across all stocks →What TRLV's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 46 | -3.9% | 41% | September 18, 2026 |
| Bollinger Band Breakdown | 24 | +2.2% | 58% | March 26, 2026 |
| Bollinger Band Breakout | 23 | -4.4% | 30% | September 22, 2026 |
| 200-Day Moving Average TouchActive now | 4 | +22.2% | 75% | May 15, 2026 |
| Any 20-session window (baseline) | -2.7% | 45% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About TRLV
Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll O…
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Employees
- 5,000
- Website
- www.trulieve.com/
Fundamentals
- 1-day range
- $10.35$11.17
- Market cap
- $1.73B
- P/E (trailing)
- —
- P/E (forward)
- 18.59
- EPS (trailing)
- $-2.46
- Dividend yield
- —
- Beta
- 0.55
- Avg. volume
- 1.43M
Forecasts
7 analyst ratings
Trulieve Cannabis Corp. Subordinate Voting Shares Competitors
Chosen by industry and closest market cap.
- TRLVTrulieve Cannabis Corp. Subordinate Voting Shares$10.01▼ 2.82%Market cap $1.73BP/E —$7.82$12.93
- CRONCronos Group Inc. Common Share$3.21▲ 0.31%Market cap $1.16BP/E 16.88$3.23$4.99
- RGCRegencell Bioscience Holdings Limited Ordinary Shares$9.59▲ 0.74%Market cap $2.70BP/E —$4.51$69
- GLASGlass House Brands Inc. Subordinate Voting Shares$3.19▼ 14.02%Market cap $760.64MP/E —$4.2$14
- TLRYTilray Brands Inc. Common Stock$3.04▼ 5.30%Market cap $517.36MP/E —$3.07$18.4
- CGCCanopy Growth Corporation Common Shares$0.713▼ 3.13%Market cap $400.49MP/E —$1.05$3.28
- RLXRLX Technology Inc. American Depositary Shares each representing the right to receive one (1) Class A ordinary share$1.7▼ 0.58%Market cap $3.08BP/E 14.19$1.65$2.6
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TRLV Trulieve Cannabis Corp. Subordinate Voting Shares | $1.73B | — | $10.01 | ▼ 2.82% | $7.82$12.93 |
| CRON Cronos Group Inc. Common Share | $1.16B | 16.88 | $3.21 | ▲ 0.31% | $3.23$4.99 |
| RGC Regencell Bioscience Holdings Limited Ordinary Shares | $2.70B | — | $9.59 | ▲ 0.74% | $4.51$69 |
| GLAS Glass House Brands Inc. Subordinate Voting Shares | $760.64M | — | $3.19 | ▼ 14.02% | $4.2$14 |
| TLRY Tilray Brands Inc. Common Stock | $517.36M | — | $3.04 | ▼ 5.30% | $3.07$18.4 |
| CGC Canopy Growth Corporation Common Shares | $400.49M | — | $0.713 | ▼ 3.13% | $1.05$3.28 |
| RLX RLX Technology Inc. American Depositary Shares each representing the right to receive one (1) Class A ordinary share | $3.08B | 14.19 | $1.7 | ▼ 0.58% | $1.65$2.6 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 185.3K
- Total value held
- $1.04M
- Institutional holders
- 6
- Unknown145.0K
- Unknown39.2K
- Unknown526
- Unknown500
- Unknown75
- Unknown46
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Trulieve Repays $65M Mortgage, Sets Q3 Earnings Date
Trulieve Cannabis announced it has repaid a $65 million mortgage, a move that strengthens its balance sheet. The company also confirmed that its third-quarter 2026 results conference call will be held on November 5, 2026. These updates provide clarity on the firm's financial structure and upcoming reporting schedule.
Trulieve Repays $65M Mortgage, Sets Q3 Earnings Date. Trulieve Cannabis announced it has repaid a $65 million mortgage, a move that strengthens its balance sheet. The company also confirmed that its third-quarter 2026 results conference call will be held on November 5, 2026. These updates provide clarity on the firm's financial structure and upcoming reporting schedule.